Novartis Vaccines is dedicated to delivering on the promise of prevention through the research, development and production of innovative, safe and effective vaccines. Our current portfolio includes products to prevent Influenza, Meningitis, Rabies, Japanese encephalitis, Tick-borne encephalitis, Haemophilus Influenzae type B (Hib), Polio, Diphtheria, Tetanus and Pertussis (whooping cough).